Related references
Note: Only part of the references are listed.Post-translational modification patterns on β-myosin heavy chain are altered in ischemic and nonischemic human hearts
Maicon Landim-Vieira et al.
ELIFE (2022)
Dilated cardiomyopathy mutation E525K in human beta-cardiac myosin stabilizes the interacting-heads motif and super-relaxed state of myosin
David Rasicci et al.
ELIFE (2022)
Synthetic thick filaments: A new avenue for better understanding the myosin super-relaxed state in healthy, diseased, and mavacamten-treated cardiac systems
Sampath K. Gollapudi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Cardiac myosin contraction and mechanotransduction in health and disease
Samantha K. Barrick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
To lie or not to lie: Super-relaxing with myosins
Suman Nag et al.
ELIFE (2021)
Pathophysiology of heart failure
Robert H. G. Schwinger
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2021)
Impact of regulatory light chain mutation K104E on the ATPase and motor properties of cardiac myosin
David Rasicci et al.
JOURNAL OF GENERAL PHYSIOLOGY (2021)
Heart Failure in Humans Reduces Contractile Force in Myocardium From Both Ventricules
Cheavar A. Blair et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)
Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy
Christopher N. Toepfer et al.
CIRCULATION (2020)
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction Rationale and Design of GALACTIC-HF
John R. Teerlink et al.
JACC-HEART FAILURE (2020)
SuperPlots: Communicating reproducibility and variability in cell biology
Samuel J. Lord et al.
JOURNAL OF CELL BIOLOGY (2020)
Mitochondrial ROS in myocardial ischemia reperfusion and remodeling
Heiko Bugger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Oxidative Stress in Ischemic Heart Disease
Aleksandar Kibel et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Heart Failure in Humans Reduces Contractile Force in Myocardium From Both Ventricles
Cheavar A. Blair et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study
Moien A. B. Khan et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy
Thomas S. O'Leary et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Carbonylation of atrial myosin prolongs its interaction with actin
G. Kopylova et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2018)
Cardiac Dysfunction and Metabolic Inflexibility in a Mouse Model of Diabetes Without Dyslipidemia
Maria Rohm et al.
DIABETES (2018)
Mitochondrial dysfunction in pathophysiology of heart failure
Bo Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Diabetes with heart failure increases methylglyoxal modifications in the sarcomere, which inhibit function
Maria Papadaki et al.
JCI INSIGHT (2018)
Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
Vicente J. Planelles-Herrero et al.
NATURE COMMUNICATIONS (2017)
Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction A Nationwide Cohort Study
Ola Vedin et al.
CIRCULATION-HEART FAILURE (2017)
Left ventricular global systolic function assessment by echocardiography
Suresh Chengode
ANNALS OF CARDIAC ANAESTHESIA (2016)
Citrullination of myofilament proteins in heart failure
Justyna Fert-Bober et al.
CARDIOVASCULAR RESEARCH (2015)
Ensemble Force Changes that Result from Human Cardiac Myosin Mutations and a Small-Molecule Effector
Tural Aksel et al.
CELL REPORTS (2015)
Modifications of myofilament protein phosphorylation and function in response to cardiac arrest induced in a swine model
Mike Woodward et al.
FRONTIERS IN PHYSIOLOGY (2015)
Hypertrophic and Dilated Cardiomyopathy: Four Decades of Basic Research on Muscle Lead to Potential Therapeutic Approaches to These Devastating Genetic Diseases
James A. Spudich
BIOPHYSICAL JOURNAL (2014)
Transmural heterogeneity of cellular level power output is reduced in human heart failure
Premi Haynes et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Nitroxyl, Redox Switches, Cardiac Myofilaments, and Heart Failure A Prequel to Novel Therapeutics?
Ying Ge et al.
CIRCULATION RESEARCH (2012)
Calcium handling in human heart failure abnormalities and target for therapy
Hannes Reuter et al.
WIENER MEDIZINISCHE WOCHENSCHRIFT (2012)
Changes in Actin Structural Transitions Associated with Oxidative Inhibition of Muscle Contraction
Ewa Prochniewicz et al.
BIOCHEMISTRY (2008)
Peroxynitrite inhibits myofibrillar protein function in an in vitro assay of motility
Jeremy H. Snook et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Myosin as a potential redox-sensor: an in vitro study
Chiara Passarelli et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2008)
Local energetic regulation of sarcoplasmic and myosin ATPase is differently impaired in rats with heart failure
Frederic Joubert et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Oxidation of myosin heavy chain and reduction in force production in hyperthyroid rat soleus
T Yamada et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Effects of peroxynitrite on isolated cardiac trabeculae: selective impact on myofibrillar energetic controllers
MJ Mihm et al.
BIOCHIMIE (2003)
Mg-ATPase and Ca2+ activated myosin ATPase activity in ventricular myofibrils from non-failing and diseased human hearts -: effects of calcium sensitizing agents MCI-154, DPI 201-106, and caffeine
C Okafor et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Myosin from failing and non-failing human ventricles exhibit similar contractile properties
T Noguchi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)